- Home
- FRSX vs PSTV Comparison
FRSX vs PSTV Comparison
Compare FRSX & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- PSTV
- Stock Information
- Founded
- FRSX N/A
- PSTV 1996
- Country
- FRSX Israel
- PSTV United States
- Employees
- FRSX N/A
- PSTV N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- PSTV Medical/Dental Instruments
- Sector
- FRSX Technology
- PSTV Health Care
- Exchange
- FRSX Nasdaq
- PSTV Nasdaq
- Market Cap
- FRSX 9.0M
- PSTV 10.4M
- IPO Year
- FRSX 2017
- PSTV N/A
- Fundamental
- Price
- FRSX $0.50
- PSTV $0.35
- Analyst Decision
- FRSX
- PSTV Strong Buy
- Analyst Count
- FRSX 0
- PSTV 3
- Target Price
- FRSX N/A
- PSTV $10.83
- AVG Volume (30 Days)
- FRSX 480.7K
- PSTV 65.3M
- Earning Date
- FRSX 08-08-2025
- PSTV 08-13-2025
- Dividend Yield
- FRSX N/A
- PSTV N/A
- EPS Growth
- FRSX N/A
- PSTV N/A
- EPS
- FRSX N/A
- PSTV N/A
- Revenue
- FRSX $436,000.00
- PSTV $5,206,000.00
- Revenue This Year
- FRSX N/A
- PSTV $14.10
- Revenue Next Year
- FRSX N/A
- PSTV $7.96
- P/E Ratio
- FRSX N/A
- PSTV N/A
- Revenue Growth
- FRSX N/A
- PSTV N/A
- 52 Week Low
- FRSX $0.45
- PSTV $0.16
- 52 Week High
- FRSX $2.63
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- FRSX 45.18
- PSTV 51.85
- Support Level
- FRSX $0.45
- PSTV $0.27
- Resistance Level
- FRSX $0.54
- PSTV $0.37
- Average True Range (ATR)
- FRSX 0.05
- PSTV 0.05
- MACD
- FRSX 0.01
- PSTV 0.02
- Stochastic Oscillator
- FRSX 35.50
- PSTV 67.04
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).